Latest Ipsen News & Updates

See the latest news and media coverage for Ipsen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ipsen

Global specialty biopharmaceutical company

ipsen.com

Headquarters: Paris, France
Company type: Public company
Number of employees: 6,500–10,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Ipsen

In short: Ipsen expanded its portfolio through strategic acquisitions and pipeline advancement, though it faced a late-stage trial failure in liver disease.

Company announcements

July 30 Ipsen

Ipsen delivers excellent H1 2026 results and upgrades guidance

Sales grew 23.5% at CER, core operating margin reached 38.6%, and full-year guidance was raised.

July 29 Ipsen

Ipsen nominates Catherine Bradley as independent Director

She succeeds Ms. Witts, effective immediately, bringing over 30 years of experience in investment banking and corporate governance.

July 24 Ipsen

Ipsen announces BOLD trial missed primary endpoint

The Phase III trial for biliary atresia did not improve native liver survival versus placebo.

July 22 Ipsen

Ipsen completes acquisition of Memo Therapeutics AG

The deal adds first-in-class asset potravitug to Ipsen's rare disease pipeline.

Media coverage

July 30 Investing.com

Results report: Ipsen exceeds revenue forecasts for H1 2026

Ipsen has raised its full-year 2026 sales forecast to more than 20% growth at constant exchange rates, compared to a...

July 30 Yahoo Finance

Ipsen SA (IPSEY) (H1 2026) Earnings Call Highlights: Record Sales and Margin...

Ipsen SA (IPSEY) reports 23.5% sales growth and a record 38.6% core operating margin, while navigating generic competition and investing in promising new launches.

July 30 Yahoo Finance

Ipsen slips despite raising outlook on broad-based drug sales growth

Shares in French drugmaker Ipsen SA slippedon Thursday even as the company’s second-quarter product sales of €1,115 million beat company-compiled consensus of €1,048 million by...

July 29 Les Echos

Ipsen raises its targets, revenue up 24.5% in Q2

July 30 (Reuters) - Ipsen raised its targets for the 2026 financial year on Thursday, after a 24.5% increase in its second-quarter revenue.

Never miss news about Ipsen

Track Ipsen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ipsen competitors & trending companies

Browse news for competitors to Ipsen and other trending companies.